투자판단관련주요경영사항 (듀켐바이오에프이에스주사액(플루오로에스트라디올(18F)액) 식품의약품안전처 품목허가 승인)[코]
Received: 12/18/2025 · Reporter: 듀켐바이오
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 13 filings
- Same category
- 8 filings
- Previous same-category filing
- 7/22/2026
- Corrections / withdrawals
- 1 filing
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).